Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CVS HEALTH CORPORATION

(CVS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health : Pharmacies Start Offering Moderna COVID-19 Booster Shots

10/22/2021 | 01:01pm EST


ę MT Newswires 2021
All news about CVS HEALTH CORPORATION
11/24MarketScreener's World Press Review - November 24, 2021
11/23Federal Jury Finds CVS, Walmart, Walgreens Contributed to Opioid Crisis in Two Ohio Cou..
MT
11/23US Jury Finds CVS, Walmart, and Walgreens Contributed to the Opioid Epidemic in Two Ohi..
MT
11/23U.s. jury finds pharmacy operators cvs health, walgreens boots alliance and walmart hel..
RE
11/23CVS Health Completes Rollout of Time Delay Safes in All 851 Texas Pharmacies
PR
11/19MarketScreener's World Press Review - November 19, 2021
11/18Health Care Up On Inflation Bets -- Health Care Roundup
DJ
11/18CVS Health to close hundreds of drugstores over next 3 years
AQ
11/18CVS Health Cuts Full-Year Earnings Guidance Amid Plan to Close 900 Stores Over Three Ye..
MT
11/18CVS to close 900 drugstores in three years to beef up health services
RE
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2021 289 B - -
Net income 2021 8 185 M - -
Net Debt 2021 48 101 M - -
P/E ratio 2021 14,5x
Yield 2021 2,18%
Capitalization 121 B 121 B -
EV / Sales 2021 0,59x
EV / Sales 2022 0,54x
Nbr of Employees 256 500
Free-Float 75,7%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | CVS | US1266501006 | MarketScreener
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 26
Last Close Price 91,52 $
Average target price 105,37 $
Spread / Average Target 15,1%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
David Wyatt Dorman Chairman
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors